Fenestra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.25 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.81 M
- Revenue Growth 0.18%
- Profit Growth 58.64%
- Ebitda 123.94%
- Net Worth 11.02%
- Total Assets 19.36%
About Fenestra Pharmaceuticals
Fenestra Pharmaceuticals Private Limited (FPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 January 2011 and has a history of 14 years and one month. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.25 M.
The company currently has active open charges totaling ₹8.81 M.
Jayasankar Gopalakrishnakurup, Sugunanambiar Bijoy, and Nimesh Elayidath serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA2011PTC056572
- Company No.
056572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Fenestra Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nimesh Elayidath  | Managing Director | 10-Jan-2011 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayasankar Gopalakrishnakurup | Director | 10-Jan-2011 | Current |
| Sugunanambiar Bijoy | Director | 10-Jan-2011 | Current |
Financial Performance of Fenestra Pharmaceuticals.
Fenestra Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.18% increase. The company also saw a substantial improvement in profitability, with a 58.64% increase in profit. The company's net worth Soared by an impressive increase of 11.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fenestra Pharmaceuticals?
Unlock access to Fenestra Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹8.81 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2022 | Hdfc Bank Limited | ₹2.51 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹2.51 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
| 09 Sep 2021 | Hdfc Bank Limited | ₹1.30 M | Open |
How Many Employees Work at Fenestra Pharmaceuticals?
Fenestra Pharmaceuticals has a workforce of 25 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fenestra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fenestra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
